X4 Pharmaceuticals Quote - XFOR

	Real-time Prices	Level 2
Australian Stock Exchange

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.393

Bid

0.3752

Offer

0.40

Volume

666,993

0.3729 Day's Range 0.40

0.2612 52 Week Range 1.60

Market Cap

67.025M

Previous Close

0.3894

Open

0.3795

Last Trade

0.382

Last Trade Time

Financial Volume

US$ 257,893

VWAP

0.38665

Average Volume (3m)

2,493,147

Shares Outstanding

170,546,469

Dividend Yield

PE Ratio

-0.66

Earnings Per Share (EPS)

-0.59

Revenue

Net Profit

-101.17M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was US$0.39. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of US$ 0.2612 to US$ 1.60.

X4 Pharmaceuticals currently has 170,546,469 shares in issue. The market capitalisation of X4 Pharmaceuticals is US$66.41 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.66.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0253	6.88060919228	0.3677	0.393	0.3316	1633094	0.35224279	CS
4	-0.1094	-21.775477707	0.5024	0.68	0.2612	5473535	0.39759509	CS
12	-0.2821	-41.7864020145	0.6751	0.7399	0.2612	2493147	0.44853624	CS
26	-0.5408	-57.9139001928	0.9338	1.13	0.2612	2167700	0.58208003	CS
52	-0.3889	-49.7378181353	0.7819	1.6	0.2612	2428451	0.82650163	CS
156	-4.237	-91.5118790497	4.63	4.6499	0.2612	1751355	1.19521898	CS
260	-10.157	-96.2748815166	10.55	12.96	0.2612	1091433	1.47886078	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BSLKBolt Projects Holdings Inc	US$ 0.71 (139.86%)	80.81M
PRZOParaZero Technologies Ltd	US$ 1.24 (94.14%)	205.02M
AIEVThunder Power Holdings Inc	US$ 0.47 (87.25%)	122.71M
PASGPassage Bio Inc	US$ 1.13 (69.52%)	15.44M
EPOWSunrise New Energy Company Ltd	US$ 1.06 (45.21%)	314.9k
APLTApplied Therapeutics Inc	US$ 2.03 (-76.31%)	42.74M
TGLTreasure Global Inc	US$ 0.2944 (-29.08%)	1.83M
PROCProcaps Group SA	US$ 1.51 (-27.75%)	98.71k
SHOTWSafety Shot Inc	US$ 0.104 (-20.00%)	1.43k
MONDMondee Holdings Inc	US$ 0.7102 (-19.59%)	297.61k
PRZOParaZero Technologies Ltd	US$ 1.24 (94.14%)	205.02M
NVDANVIDIA Corporation	US$ 138.25 (2.15%)	141.86M
AIEVThunder Power Holdings Inc	US$ 0.47 (87.25%)	122.71M
RGTIRigetti Computing Inc	US$ 3.05 (27.08%)	116.98M
MARAMARA Holdings Inc	US$ 27.42 (1.86%)	89.54M